| Date Filed | Type | Description |
| 02/07/2023 |
4
| George Jean (Director) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Granted 14,150 options to buy
@ $1.69, valued at
$23.9k
|
|
| 02/24/2022 |
4
| George Jean (Director) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Granted 14,150 options to buy
@ $5.96, valued at
$84.3k
|
|
| 12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2021 |
4
| George Jean (Director) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Converted 2,444,268 shares
@ $0
Converted 7,500,000 convertible preferred
@ $0
Converted 832,026 convertible preferred
@ $0 |
|
| 06/17/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
3
| George Jean (10% Owner) has filed a Form 3 on Gemini Therapeutics, Inc. /DE |
| 07/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/22/2020 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 07/16/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/11/2020 |
4
| George Jean (Director) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $5.25, valued at
$105k
|
|
| 01/24/2020 |
4
| George Jean (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Granted 1,377 shares
@ $0
Granted 8,185 options to buy
@ $52.99, valued at
$433.7k
|
|
| 06/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2019 |
4
| George Jean (Director) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 11,000 options to buy
@ $5.42, valued at
$59.6k
|
|
| 01/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2018 |
4
| George Jean (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 14,000 options to buy
@ $1.48, valued at
$20.7k
|
|
| 06/04/2018 |
4
| George Jean (Director) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 11,000 options to buy
@ $5.15, valued at
$56.7k
|
|
| 03/05/2018 |
4
| George Jean (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Granted 1,250 shares
@ $0
Granted 7,500 options to buy
@ $40.61, valued at
$304.6k
|
|
| 12/18/2017 |
4
| George Jean (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Sold 105,122 shares
@ $35.73, valued at
$3.8M
|
|
| 07/28/2017 |
4
| George Jean (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 6,500 options to buy
@ $1.27, valued at
$8.3k
|
|
| 06/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/14/2017 |
4
| George Jean (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Granted 1,250 shares
@ $0
Granted 7,500 options to buy
@ $30.17, valued at
$226.3k
|
|
| 12/19/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/04/2016 |
4
| George Jean (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Sold 857,145 shares
@ $35.5, valued at
$30.4M
|
|
| 06/16/2016 |
4
| George Jean (10% Owner) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 11,000 options to buy
@ $4.76, valued at
$52.4k
|
|
| 03/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/20/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/30/2013 |
4
| George Jean (Director) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Converted 58,129 shares
@ $0
Converted 27,939 shares
@ $0
Converted 1,448,580 shares
@ $0
Converted 8,632 shares
@ $0
Converted 37,379 preferred shares
@ $0
Converted 17,966 preferred shares
@ $0
Converted 931,468 preferred shares
@ $0
Converted 5,551 preferred shares
@ $0
Converted 17,302 preferred shares
@ $0
Converted 8,316 preferred shares
@ $0
Converted 431,173 preferred shares
@ $0 |
|
| 06/18/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/18/2011 |
3
| Form 3 - Initial statement of beneficial ownership of securities |